Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome. - Wikidata - awgldk - TriplyDB

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

http://www.wikidata.org/entity/Q37210734

about

Plasticity of Candida albicans Biofilms In vitro studies of activities of some antifungal agents against Candida albicans ATCC 10231 by the turbidimetric method Fluconazole susceptibility testing of Candida albicans: microtiter method that is independent of inoculum size, temperature, and time of reading Effects of pentamidine alone and in combination with ketoconazole or itraconazole on the growth of Candida albicans Chemerin is an antimicrobial agent in human epidermis.Collaborative investigation of variables in susceptibility testing of yeasts.Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.Improved medium for fluconazole susceptibility testing of Candida albicans.Analysis of growth characteristics of filamentous fungi in different nutrient media.Sensitive bioassay for determination of fluconazole concentrations in plasma using a Candida albicans mutant hypersusceptible to azoles.Antifungal susceptibility tests.Effects of temperature on anti-Candida activities of antifungal antibiotics.Susceptibility testing of fungi: current status of correlation of in vitro data with clinical outcome.Epidemiological analysis of Candida albicans strains by multilocus enzyme electrophoresis.Two-site comparison of broth microdilution and semisolid agar dilution methods for susceptibility testing of Cryptococcus neoformans in three media.Comparison study of broth macrodilution and microdilution antifungal susceptibility tests.Susceptibility testing of Cryptococcus neoformans: a microdilution technique Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests.Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents.In vitro susceptibilities and biotypes of Candida albicans isolates from the oral cavities of patients infected with human immunodeficiency virus.Quantitative microculture system with standardized inocula for strain typing, susceptibility testing, and other physiologic measurements with Candida albicans and other yeasts.Antifungal susceptibility testing Regulation of chemerin chemoattractant and antibacterial activity by human cysteine cathepsins.

P2860

Q26744150-725D6050-E409-4A1D-8930-6EA11252C3B9 Q28318358-3C0A319A-CAD5-4CD1-8C55-77D29B0F848F Q28326328-035B2F55-455E-44E5-961E-0FBC5081BF08 Q28334101-C0E25C18-C8D0-47F4-BED0-DB8B965241DC Q30032660-4C46595A-44E6-459E-B1FA-3DCFC24D2BDD Q30451715-373EEB00-9EA5-4C44-A420-BB12C980FE28 Q33684486-A373ABC7-4A2B-413A-9A92-1BB02EE102E5 Q33747088-896DEAB9-DB1A-4E8C-8FD0-13D38601C339 Q33971124-396401A9-D8B1-4C79-98B1-64FDD72563ED Q33981566-55DE2E38-F8FB-4E8E-9548-02B4596C1482 Q35562348-A2CF1B64-6561-4EFA-8C1E-62847B4AC00E Q35811074-09EECEB2-4689-4CC5-A8EC-44A2F33192AB Q36528018-E50A1660-2847-4E68-BD3D-8E3FDB25555C Q37063549-D86D5C09-A137-4B90-BA3D-9224FAB5EE52 Q37068914-356EDBBF-D2AE-45E7-B965-152F3B529E98 Q37235331-AF4746F8-3F05-41B3-9CB9-4C533D6731C7 Q37249636-153F71BC-76F1-4D71-A8F1-C4EFA24CD791 Q37251197-C8B9B20B-2E5A-4B28-B6AC-A3C3DC89F524 Q39881200-3AF83A4A-A0BC-40F3-BB32-7686F766B61A Q40196868-99A92CAD-B036-4C1E-8372-CAFB4ACFA97F Q40214454-5538D839-DB8C-49FE-A1EC-2B1E18FE084F Q40795131-EA466477-681B-417D-9FD2-8AEE44ED8F05 Q42834477-69B8E3E7-83F0-4334-A57C-9AFB613D9052

P2860

Microtiter broth dilution method for yeast susceptibility testing with validation by clinical outcome.

http://www.wikidata.org/entity/Q37210734

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on October 1986

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Microtiter broth dilution meth ...... alidation by clinical outcome.

@en

Microtiter broth dilution meth ...... alidation by clinical outcome.

@nl

type

label

Microtiter broth dilution meth ...... alidation by clinical outcome.

@en

Microtiter broth dilution meth ...... alidation by clinical outcome.

@nl

prefLabel

Microtiter broth dilution meth ...... alidation by clinical outcome.

@en

Microtiter broth dilution meth ...... alidation by clinical outcome.

@nl

P1433

Q37210734-9C68E423-7F96-454B-8AA9-C22E1A023559

P1476

Q37210734-C7151EAA-FCE5-4B4E-AE1B-5F8768026280

P2093

Q37210734-50D8C0DF-E9DE-43C7-9F83-120CBA5C22BC

Q37210734-73248590-CEE0-47A1-9C5F-443AE8535485

Q37210734-84BB81EF-C5FB-42E5-B3D4-309A7794FDBE

Q37210734-A7DF3BF5-51C0-4523-BC80-4F1E61E333D8

P2860

Q37210734-003E00E4-1855-4355-8A47-DF5180A945E7

Q37210734-02C2FAF3-0049-4160-BE91-3530675BD16D

Q37210734-0E79B3D3-DD55-48B7-A932-EED1BB1CCE7A

Q37210734-1C62F024-CD73-40F6-9A52-9DF697F4415B

Q37210734-2FC9119F-AA11-4D22-AF4C-0E700F52DB72

Q37210734-3523EE74-0097-4987-AD15-1881A93D70E2

Q37210734-3FA70FDB-9DCF-4AB1-A9D7-DF351B284EFA

Q37210734-5461E979-B584-4B4C-B637-197800A54DE9

Q37210734-5D6A325C-800A-491B-BB9B-7DEF2F4A34E5

Q37210734-68816092-9841-4753-8678-E340247F086D

P304

Q37210734-5727A9C6-8A02-4C2A-92F5-AA30A3DEE04F

P31

Q37210734-AB10CF66-0863-471B-A5BF-6AB045B5F9B3

P407

Q37210734-04FE7498-E0E1-4833-AF7B-8DDA85ABCA9B

P433

Q37210734-50B1B864-D1F9-4AAE-8252-5A99430C1A65

P478

Q37210734-3FA79C59-362B-4129-8C78-6FB42AF1C26D

P577

Q37210734-0F52466B-C520-4AD2-8357-202207252D21

P698

Q37210734-91D57BBD-4B68-4029-AF4D-D3BA4BD2A07A

P932

Q37210734-E6C18DDF-B303-4002-91A9-8AE6F09E5DA6

P1433

Journal of Clinical Microbiology

P1476

Microtiter broth dilution meth ...... alidation by clinical outcome.

@en

P2093

Radetsky M

http://www.w3.org/2001/XMLSchema#string

Roe MH

http://www.w3.org/2001/XMLSchema#string

Todd JK

http://www.w3.org/2001/XMLSchema#string

Wheeler RC

http://www.w3.org/2001/XMLSchema#string

P2860

Tablet sensitivity testing on pathogenic fungi

Antimicrobial susceptibility testing of yeasts: a turbidimetric technique independent of inoculum size

Susceptibility to 5-fluorocytosine and prevalence of serotype in 402 Candida albicans isolates from the United States.

Turbidimetric studies of growth inhibition of yeasts with three drugs: inquiry into inoculum-dependent susceptibility testing, time of onset of drug effect, and implications for current and newer methods.

Disk agar diffusion susceptibility testing of yeasts

Results of a survey of antifungal susceptibility tests in the United States and interlaboratory comparison of broth dilution testing of flucytosine and amphotericin B

Neonatal systemic candidiasis: a failure to respond to intravenous miconazole in two neonates.

Factors influencing the susceptibility of Candida albicans to the polyenoic antibiotics nystatin and amphotericin B.

Severe candidal infections: clinical perspective, immune defense mechanisms, and current concepts of therapy.

Comparison of amphotericin B and N-D-ornithyl amphotericin B methyl ester in experimental cryptococcal meningitis and Candida albicans endocarditis with pyelonephritis

P304

600-606

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

24

http://www.w3.org/2001/XMLSchema#string

P577

1986-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

3771749

http://www.w3.org/2001/XMLSchema#string

P932

268979

http://www.w3.org/2001/XMLSchema#string